Look through per level per nominee, not full beneficial shareholder analysis which cost $2k -$3k per report. Keep trying mate....actually you won't win cause I've used the reports before at board level & know all the pricing, across competitors. Keep telling me I'm wrong....it just makes you look less intelligent with every post. #Gobbleroftheyear
Look through per level per nominee, not full beneficial...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $371.1M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8444 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 125000 | 1 |
View Market Depth
| Last trade - 16.16pm 24/07/2024 (20 minute delay) ? |
| BRN (ASX) Chart |
Day chart unavailable